Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study.

Spoto B, Kakkar R, Lo L, Devalaraja M, Pizzini P, Torino C, Leonardis D, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C.

J Clin Med. 2019 Apr 16;8(4). pii: E523. doi: 10.3390/jcm8040523.

2.

Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease.

Panuccio V, Pizzini P, Parlongo G, Caridi G, Tripepi R, Mafrica A, Cutrupi S, D'Arrigo G, Porto G, Garofalo C, Provenzano M, Tripepi G, Mallamaci F, Plebani M, Zoccali C.

Clin Chem Lab Med. 2019 Feb 12. pii: /j/cclm.ahead-of-print/cclm-2018-1227/cclm-2018-1227.xml. doi: 10.1515/cclm-2018-1227. [Epub ahead of print]

PMID:
30753154
3.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Iannello A, Rolla S, Maglione A, Ferrero G, Bardina V, Inaudi I, De Mercanti S, Novelli F, D'Antuono L, Cardaropoli S, Todros T, Turrini MV, Cordioli C, Puorro G, Marsili A, Lanzillo R, Brescia Morra V, Cordero F, De Bortoli M, Durelli L, Visconti A, Cutrupi S, Clerico M.

Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.

4.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.

Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group.

Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

5.

Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.

D'arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2019 May 1;34(5):819-824. doi: 10.1093/ndt/gfy085.

PMID:
29668990
6.

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.

Torino C, Pizzini P, Cutrupi S, Tripepi R, Vilasi A, Tripepi G, Mallamaci F, Zoccali C.

Oxid Med Cell Longev. 2017;2017:2801324. doi: 10.1155/2017/2801324. Epub 2017 Dec 6.

7.

Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Borgoni S, Iannello A, Cutrupi S, Allavena P, D'Incalci M, Novelli F, Cappello P.

Oncoimmunology. 2017 Nov 13;7(2):e1393596. doi: 10.1080/2162402X.2017.1393596. eCollection 2018.

8.

Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.

Spoto B, Pizzini P, Cutrupi S, Tripepi G, Curatola G, Mallamaci F, Zoccali C.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):291-297. doi: 10.1016/j.numecd.2017.11.010. Epub 2017 Dec 7.

PMID:
29307660
9.

Vitamin D and methylarginines in chronic kidney disease (CKD).

Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

PLoS One. 2017 Oct 4;12(10):e0185449. doi: 10.1371/journal.pone.0185449. eCollection 2017.

10.

Intact FGF23 and α-klotho during acute inflammation/sepsis in CKD patients.

Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.

Eur J Clin Invest. 2017 Jun;47(6):470-472. doi: 10.1111/eci.12765. No abstract available.

PMID:
28489248
11.

Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.

Torino C, Pizzini P, Cutrupi S, Tripepi G, Mallamaci F, Thadhani R, Zoccali C.

Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):260-266. doi: 10.1016/j.numecd.2016.11.005. Epub 2016 Nov 23.

PMID:
28017524
12.

A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells.

Reineri S, Agati S, Miano V, Sani M, Berchialla P, Ricci L, Iannello A, Coscujuela Tarrero L, Cutrupi S, De Bortoli M.

PLoS One. 2016 Dec 19;11(12):e0168639. doi: 10.1371/journal.pone.0168639. eCollection 2016.

13.

E2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells.

Guglielmotto M, Reineri S, Iannello A, Ferrero G, Vanzan L, Miano V, Ricci L, Tamagno E, De Bortoli M, Cutrupi S.

Front Cell Neurosci. 2016 Jun 1;10:147. doi: 10.3389/fncel.2016.00147. eCollection 2016.

14.

Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.

Zoccali C, Torino C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Ghiadoni L, Thadhani R, Tripepi G, Mallamaci F.

Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):581-589. doi: 10.1016/j.numecd.2016.03.008. Epub 2016 Mar 25.

PMID:
27113290
15.

Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.

Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.

Eur J Clin Invest. 2016 Mar;46(3):234-41. doi: 10.1111/eci.12588. Epub 2016 Jan 21.

PMID:
26728476
16.

Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients.

Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.

Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):80-3. doi: 10.1016/j.numecd.2015.10.004. Epub 2015 Nov 4. No abstract available.

PMID:
26712271
17.

Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.

Miano V, Ferrero G, Reineri S, Caizzi L, Annaratone L, Ricci L, Cutrupi S, Castellano I, Cordero F, De Bortoli M.

Oncotarget. 2016 Jan 19;7(3):3201-16. doi: 10.18632/oncotarget.6420.

18.

Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

Spoto B, Mattace-Raso F, Sijbrands E, Leonardis D, Testa A, Pisano A, Pizzini P, Cutrupi S, Parlongo RM, D'Arrigo G, Tripepi G, Mallamaci F, Zoccali C.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):232-40. doi: 10.2215/CJN.07000714. Epub 2014 Dec 9.

19.

Paricalcitol and endothelial function in chronic kidney disease trial.

Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, Ghiadoni L, Thadhani R, Mallamaci F.

Hypertension. 2014 Nov;64(5):1005-11. doi: 10.1161/HYPERTENSIONAHA.114.03748. Epub 2014 Aug 4. Erratum in: Hypertension. 2015 Jun;65(6):e48. Erratum in: Hypertension. 2017 Jul;70(1):e1.

PMID:
25259743
20.

Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity.

Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E, Vilardi A, Parlongo RM, Pizzini P, Pisano A, Vermi W, Testa A, Cutrupi S, D'Arrigo G, Lonardi S, Tripepi G, Cancarini G, Zoccali C.

Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1137-43. doi: 10.1016/j.numecd.2014.04.017. Epub 2014 May 27.

PMID:
24984824
21.

Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.

Caizzi L, Ferrero G, Cutrupi S, Cordero F, Ballaré C, Miano V, Reineri S, Ricci L, Friard O, Testori A, Corà D, Caselle M, Di Croce L, De Bortoli M.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4892-7. doi: 10.1073/pnas.1315445111. Epub 2014 Mar 17.

22.

Genomic lens on neuroglobin transcription.

Cutrupi S, Ferrero G, Reineri S, Cordero F, De Bortoli M.

IUBMB Life. 2014 Jan;66(1):46-51. doi: 10.1002/iub.1235. Epub 2014 Jan 6.

23.

Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients.

Spoto B, Mattace-Raso F, Sijbrands E, Pizzini P, Cutrupi S, D'Arrigo G, Tripepi G, Zoccali C, Mallamaci F.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv181-7. doi: 10.1093/ndt/gft365. Epub 2013 Aug 23.

PMID:
23975745
24.

Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial.

Mallamaci F, Leonardis D, Pizzini P, Cutrupi S, Tripepi G, Zoccali C.

J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430. doi: 10.1097/HJH.0b013e328360ddd5.

PMID:
23743803
25.

The role of Transposable Elements in shaping the combinatorial interaction of Transcription Factors.

Testori A, Caizzi L, Cutrupi S, Friard O, De Bortoli M, Cora' D, Caselle M.

BMC Genomics. 2012 Aug 16;13:400. doi: 10.1186/1471-2164-13-400.

26.

Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.

Cutrupi S, Reineri S, Panetto A, Grosso E, Caizzi L, Ricci L, Friard O, Agati S, Scatolini M, Chiorino G, Lykkesfeldt AE, De Bortoli M.

Oncogene. 2012 Oct 4;31(40):4353-61. doi: 10.1038/onc.2011.627. Epub 2012 Jan 16. Erratum in: Oncogene. 2012 Oct 4;31(40):4420.

27.

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.

Spoto B, Leonardis D, Parlongo RM, Pizzini P, Pisano A, Cutrupi S, Testa A, Tripepi G, Zoccali C, Mallamaci F.

Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):981-8. doi: 10.1016/j.numecd.2011.01.005. Epub 2011 Sep 8.

PMID:
21906921
28.

Dysregulation of SREBP2 induces BACE1 expression.

Mastrocola R, Guglielmotto M, Medana C, Catalano MG, Cutrupi S, Borghi R, Tamagno E, Boccuzzi G, Aragno M.

Neurobiol Dis. 2011 Oct;44(1):116-24. doi: 10.1016/j.nbd.2011.06.010. Epub 2011 Jun 25.

29.

Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD).

Tripepi G, Mattace-Raso F, Pizzini P, Cutrupi S, Witteman J, Zoccali C, Mallamaci F.

J Nephrol. 2012 Jan-Feb;25(1):75-83. doi: 10.5301/JN.2011.7740.

PMID:
21534240
30.

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).

Leonardis D, Basta G, Mallamaci F, Cutrupi S, Pizzini P, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):748-55. doi: 10.1016/j.numecd.2010.11.008. Epub 2011 Apr 5.

PMID:
21470837
31.

Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.

Zoccali C, Postorino M, Marino C, Pizzini P, Cutrupi S, Tripepi G; CREDIT Working Group.

J Intern Med. 2011 Feb;269(2):172-81. doi: 10.1111/j.1365-2796.2010.02288.x. Epub 2010 Dec 8.

32.

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.

Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Kidney Int. 2010 Feb;77(3):225-31. doi: 10.1038/ki.2009.419. Epub 2009 Nov 18.

33.

Vitamin D levels and patient outcome in chronic kidney disease.

Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C.

Kidney Int. 2009 Jan;75(1):88-95. doi: 10.1038/ki.2008.501. Epub 2008 Oct 8.

34.

Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.

Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C.

J Hypertens. 2008 Sep;26(9):1875-82. doi: 10.1097/HJH.0b013e328307c3d2.

PMID:
18698224
35.

Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease.

Panichi V, Mantuano E, Paoletti S, Santi S, Manca Rizza G, Cutrupi S, Pizzini P, Spoto B, Tripepi G, Zoccali C.

J Nephrol. 2008 Jan-Feb;21(1):38-44.

PMID:
18264935
36.

Urotensin II and cardiomyopathy in end-stage renal disease.

Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Pizzini P, Cutrupi S, Malatino L.

Hypertension. 2008 Feb;51(2):326-33. Epub 2007 Dec 17.

PMID:
18086953
37.

Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.

Panuccio V, Cutrupi S, Pizzini P, Mallamaci F, Tripepi G, Zoccali C.

Am J Kidney Dis. 2007 Dec;50(6):1001-8.

PMID:
18037100
38.

Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane ruffling.

Chianale F, Cutrupi S, Rainero E, Baldanzi G, Porporato PE, Traini S, Filigheddu N, Gnocchi VF, Santoro MM, Parolini O, van Blitterswijk WJ, Sinigaglia F, Graziani A.

Mol Biol Cell. 2007 Dec;18(12):4859-71. Epub 2007 Sep 26.

39.

Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility.

Baldanzi G, Cutrupi S, Chianale F, Gnocchi V, Rainero E, Porporato P, Filigheddu N, van Blitterswijk WJ, Parolini O, Bussolino F, Sinigaglia F, Graziani A.

Oncogene. 2008 Feb 7;27(7):942-56. Epub 2007 Aug 13.

PMID:
17700527
40.

Diacylglycerol kinase is required for HGF-induced invasiveness and anchorage-independent growth of MDA-MB-231 breast cancer cells.

Filigheddu N, Cutrupi S, Porporato PE, Riboni F, Baldanzi G, Chianale F, Fortina E, Piantanida P, De Bortoli M, Vacca G, Graziani A, Surico N.

Anticancer Res. 2007 May-Jun;27(3B):1489-92.

41.

Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells.

Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghè C, Fubini A, Surico N, Sinigaglia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A.

Mol Biol Cell. 2007 Mar;18(3):986-94. Epub 2007 Jan 3.

42.

Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.

Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G, Boger R.

Nephrol Dial Transplant. 2007 Mar;22(3):801-6. Epub 2006 Dec 13.

PMID:
17166859
43.

Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.

Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2007 Feb;22(2):538-44. Epub 2006 Nov 2.

PMID:
17082213
44.

Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.

Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino LS, Bonanno G, Seminara G.

J Hypertens. 2006 Oct;24(10):2039-46.

PMID:
16957565
45.

Low triiodothyronine and survival in end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P.

Kidney Int. 2006 Aug;70(3):523-8. Epub 2006 Jun 14.

46.

Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.

Mallamaci F, Cutrupi S, Pizzini P, Tripepi G, Zoccali C.

Am J Hypertens. 2006 May;19(5):505-10.

PMID:
16647624
47.

Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino L.

Kidney Int. 2006 Apr;69(7):1253-8.

48.

Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.

Mallamaci F, Cutrupi S, Pizzini P, Tripepi G, Zoccali C.

J Nephrol. 2005 Nov-Dec;18(6):727-32.

PMID:
16358231
49.

Low triiodothyronine: a new facet of inflammation in end-stage renal disease.

Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F.

J Am Soc Nephrol. 2005 Sep;16(9):2789-95. Epub 2005 Jul 20.

50.

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C.

Kidney Int. 2005 Jun;67(6):2330-7.

Supplemental Content

Loading ...
Support Center